AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Accounts Payable of -$1.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $3.08M, a 21.13% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$4.99M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.15M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.81M, a 74.51% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2025 was $1.75M, a 73.55% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2024 was $6.60M.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$8.73M, a 354.16% decline from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in accounts payable for fiscal 2022 was $3.44M, a 84.43% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$1.91M 10-Q · filed 2026-07-30 | -$3.06M derived: sum of 3 quarters · filed 2026-07-30 | -$1.25M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$4.99M 10-Q · filed 2026-04-29 | -$6.14M derived: sum of 2 quarters · filed 2026-04-29 | -$4.33M derived: sum of 3 quarters · filed 2026-04-29 | -$426.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $662.00K derived: sum of 2 quarters · filed 2026-02-12 | $4.57M derived: sum of 3 quarters · filed 2026-07-30 | $1.75M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.71M derived: sum of 2 quarters · filed 2026-07-30 | $2.89M 10-Q · filed 2025-10-30 | $2.13M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.08M 10-Q · filed 2026-07-30 | $328.00K derived: sum of 3 quarters · filed 2026-07-30 | $7.42M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$2.82M 10-Q · filed 2026-04-29 | -$3.58M derived: sum of 2 quarters · filed 2026-04-29 | $3.51M derived: sum of 3 quarters · filed 2026-04-29 | $2.35M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | -$756.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $6.33M derived: sum of 2 quarters · filed 2026-02-12 | $5.17M derived: sum of 3 quarters · filed 2026-02-12 | $6.60M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $7.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $5.93M derived: sum of 2 quarters · filed 2025-10-30 | $7.36M 10-Q · filed 2025-10-30 | $3.83M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $268.00K 10-Q · filed 2025-07-31 | -$3.26M derived: sum of 3 quarters · filed 2026-02-12 | -$1.63M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-03-31 | $1.43M 10-Q · filed 2025-05-01 | -$2.10M derived: sum of 2 quarters · filed 2026-02-12 | -$466.00K derived: sum of 3 quarters · filed 2026-02-12 | $2.49M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2023-12-31 | -$3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$1.90M derived: sum of 2 quarters · filed 2026-02-12 | $1.06M derived: sum of 3 quarters · filed 2026-02-12 | -$8.73M 10-K · filed 2026-02-12 | ||||
| 2023-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $4.59M derived: sum of 2 quarters · filed 2024-10-31 | -$5.20M 10-Q · filed 2024-10-31 | $2.86M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$6.84M 10-Q · filed 2024-08-01 | $1.23M derived: sum of 3 quarters · filed 2025-02-13 | $3.84M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | -$9.80M 10-Q · filed 2024-05-02 | -$1.73M derived: sum of 2 quarters · filed 2025-02-13 | $883.00K derived: sum of 3 quarters · filed 2025-02-13 | -$1.35M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $8.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $10.68M derived: sum of 2 quarters · filed 2025-02-13 | $8.44M derived: sum of 3 quarters · filed 2025-02-13 | $3.44M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $2.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $379.00K derived: sum of 2 quarters · filed 2023-11-02 | -$4.63M 10-Q · filed 2023-11-02 | $572.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$7.24M 10-Q · filed 2023-08-03 | -$2.04M derived: sum of 3 quarters · filed 2024-02-15 | $181.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$5.01M 10-Q · filed 2023-05-04 | $193.00K derived: sum of 2 quarters · filed 2024-02-15 | $2.42M derived: sum of 3 quarters · filed 2024-02-15 | -$203.00K derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $7.42M derived: sum of 2 quarters · filed 2024-02-15 | $4.80M derived: sum of 3 quarters · filed 2024-02-15 | $1.86M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $2.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$396.00K derived: sum of 2 quarters · filed 2022-11-03 | -$3.34M 10-Q · filed 2022-11-03 | $3.05M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$5.56M 10-Q · filed 2022-08-04 | $825.00K derived: sum of 3 quarters · filed 2023-02-23 | $331.00K derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | -$2.94M 10-Q · filed 2022-05-05 | $3.44M derived: sum of 2 quarters · filed 2023-02-23 | $2.95M derived: sum of 3 quarters · filed 2023-02-23 | $1.27M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.89M derived: sum of 2 quarters · filed 2023-02-23 | $4.21M derived: sum of 3 quarters · filed 2023-02-23 | $3.33M 10-K · filed 2023-02-23 | $5.89M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | -$494.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$2.17M derived: sum of 2 quarters · filed 2021-11-03 | -$3.06M 10-Q · filed 2021-11-03 | -$7.64M 10-Q · filed 2020-11-05 | -$1.54M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$2.56M 10-Q · filed 2021-07-29 | -$7.52M 10-Q · filed 2020-07-30 | -$1.05M derived: sum of 3 quarters · filed 2022-02-24 | $3.47M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$883.00K 10-Q · filed 2021-04-29 | -$2.01M 10-Q · filed 2020-04-30 | $630.00K derived: sum of 2 quarters · filed 2022-02-24 | $5.15M derived: sum of 3 quarters · filed 2022-02-24 | $8.22M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.04M derived: sum of 2 quarters · filed 2022-02-24 | $9.10M derived: sum of 3 quarters · filed 2022-02-24 | $4.16M 10-K · filed 2022-02-24 | $3.72M 10-K · filed 2020-02-19 | |||
| 2019-09-30 | $4.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $7.59M derived: sum of 2 quarters · filed 2020-11-05 | $2.65M 10-Q · filed 2020-11-05 | $2.99M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$1.87M 10-Q · filed 2020-07-30 | -$1.53M derived: sum of 3 quarters · filed 2021-02-25 | -$1.16M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$4.94M 10-Q · filed 2020-04-30 | -$4.60M derived: sum of 2 quarters · filed 2021-02-25 | -$4.23M derived: sum of 3 quarters · filed 2021-02-25 | -$5.96M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $710.00K derived: sum of 2 quarters · filed 2021-02-25 | -$1.02M derived: sum of 3 quarters · filed 2021-02-25 | -$5.49M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$1.36M derived: sum of 2 quarters · filed 2019-10-31 | -$5.83M 10-Q · filed 2019-10-31 | -$1.24M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$6.20M 10-Q · filed 2019-08-01 | -$1.61M derived: sum of 3 quarters · filed 2020-02-19 | -$5.80M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | -$4.47M 10-Q · filed 2019-05-02 | $118.00K derived: sum of 2 quarters · filed 2020-02-19 | -$4.07M derived: sum of 3 quarters · filed 2020-02-19 | $1.85M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $4.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $399.00K derived: sum of 2 quarters · filed 2020-02-19 | $6.32M derived: sum of 3 quarters · filed 2020-02-19 | $5.33M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$4.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.74M derived: sum of 2 quarters · filed 2018-11-01 | $742.00K 10-Q · filed 2018-11-01 | $2.58M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-06-30 | $5.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $4.93M 10-Q · filed 2018-08-02 | $6.76M derived: sum of 3 quarters · filed 2019-02-14 | $4.68M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-03-31 | -$994.00K 10-Q · filed 2018-05-04 | $839.00K derived: sum of 2 quarters · filed 2019-02-14 | -$1.25M derived: sum of 3 quarters · filed 2019-02-14 | $2.80M derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2016-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$254.00K derived: sum of 2 quarters · filed 2019-02-14 | $3.79M derived: sum of 3 quarters · filed 2019-02-14 | $3.50M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $1.96M derived: sum of 2 quarters · filed 2017-11-01 | $1.67M 10-Q · filed 2017-11-01 | $7.21M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $3.75M 10-Q · filed 2017-08-08 | $9.29M derived: sum of 3 quarters · filed 2018-02-14 | $9.18M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-03-31 | -$293.00K 10-Q · filed 2017-05-04 | $5.25M derived: sum of 2 quarters · filed 2018-02-14 | $5.13M derived: sum of 3 quarters · filed 2018-02-14 | $6.59M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2015-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $5.42M derived: sum of 2 quarters · filed 2018-02-14 | $6.88M derived: sum of 3 quarters · filed 2018-02-14 | $4.21M 10-K · filed 2018-02-14 | ||||
| 2015-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.34M derived: sum of 2 quarters · filed 2016-11-03 | -$1.32M 10-Q · filed 2016-11-03 | $3.90M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-06-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$1.21M 10-Q · filed 2016-08-08 | $4.01M derived: sum of 3 quarters · filed 2017-02-16 | $4.68M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2015-03-31 | -$2.67M 10-Q · filed 2016-05-09 | $2.56M derived: sum of 2 quarters · filed 2017-02-16 | $3.23M derived: sum of 3 quarters · filed 2017-02-16 | $4.19M derived: sum of 4 quarters · filed 2017-02-16 | ||||
| 2014-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $5.89M derived: sum of 2 quarters · filed 2017-02-16 | $6.86M derived: sum of 3 quarters · filed 2017-02-16 | $7.58M 10-K · filed 2017-02-16 | ||||
| 2014-09-30 | $670.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.63M derived: sum of 2 quarters · filed 2015-11-06 | $2.35M 10-Q · filed 2015-11-06 | $3.56M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $964.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.68M 10-Q · filed 2015-08-07 | $2.89M derived: sum of 3 quarters · filed 2016-02-26 | $1.99M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $720.00K 10-Q · filed 2015-05-11 | $1.93M derived: sum of 2 quarters · filed 2016-02-26 | $1.02M derived: sum of 3 quarters · filed 2016-02-26 | -$79.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $301.00K derived: sum of 2 quarters · filed 2016-02-26 | -$799.00K derived: sum of 3 quarters · filed 2016-02-26 | $30.00K 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | -$907.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$2.01M derived: sum of 2 quarters · filed 2014-11-07 | -$1.18M 10-Q · filed 2014-11-07 | -$919.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$271.00K 10-Q · filed 2014-08-07 | -$12.00K derived: sum of 3 quarters · filed 2015-02-24 | $276.00K derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $829.00K 10-Q · filed 2014-05-09 | $1.09M derived: sum of 2 quarters · filed 2015-02-24 | $1.38M derived: sum of 3 quarters · filed 2015-02-24 | |||||
| 2012-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $547.00K derived: sum of 2 quarters · filed 2015-02-24 | -$322.00K 10-K · filed 2015-02-24 | |||||
| 2012-09-30 | $288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$581.00K 10-Q · filed 2013-11-07 | ||||||
| 2012-06-30 | -$869.00K 10-Q · filed 2013-09-05 | |||||||
| 2011-12-31 | $809.00K 10-K · filed 2014-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |